Brand profile · Biotechnology Research

AUM Biosciences

AUM Biosciences works in Biotechnology Research, out of Singapore. Ownership is privately held; it publishes at aumbiosciences.com. The record carries three addresses across three office countries. The record counts 19 people. Tagged biotech, oncology and cancer. One Singapore registration (UEN) is a confirmed match. The latest round on record is Series A at US$27.0M. The record links four similar brands, most of them in Biotechnology Research.

Profile live Privately Held Founded 2018 1 entity UEN 3 office countries US$ 27.0M Series A
Registry verified · ACRA

Key facts

Counted staff
19
self-reported 11–50 band
Founded
2018
8 years
Legal entities
1
ACRA
Office countries
3
3 addresses
Funding rounds
2
Series A · Nov 2021 · US$ 27.0M
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

Legal entities

AUM Biosciences: 1 registry entityAUM Biosciences is linked to 1 registry entity: AUM BIOSCIENCES PTE. LTD. (UEN 201810204D, confirmed).AUM BiosciencesAUM BIOSCIENCES PTE.LTD.UEN 201810204DConfirmed · ACRA
Show as table · AUM Biosciences: 1 registry entity
AUM Biosciences: 1 registry entity
AUM BIOSCIENCES PTE. LTD.UEN 201810204D
Confirmed matches1 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance

Specialties

All 8 specialties
  • biotech
  • oncology
  • drug development
  • Asian-biotech
  • Precision medicine
  • Digitalhealth
  • cancer
  • small molecules

Locations

3
Countries with an office address3 addresses on record
SingaporeprimaryAustraliaUnited States

Country footprint

Offices in 3 countriesCountry footprint: 3 countries, primary SG. Codes: SG, AU, US.3 countriesprimary SGSGAUUS
Show as table · Offices in 3 countries
Offices in 3 countries
Countries3
Primary countrySG

All codes: SG AU US

Addresses

  • SG10 Collyer Quay; Level 40; Singapore, Singapore 049315Primary
  • US251 Little Falls Dr; Wilmington, Delaware 19808
  • AU8 Gipps St; Collingwood, Victoria 3066

Grid intelligence Members

Funding

Last round · 12 November 2021US$ 27.0MSeries A · investors: SPRIM, Everlife
Rounds2
Round typeSeries A · venture round
Amount (USD)27,000,000
Stage rank3
Investors named2
Since last round4 yr 2 mo

Funding

2 funding roundsFunding timeline. Latest round 12 Nov 2021: Series A, US$ 27.0M.20182026Series AUS$ 27.0M2 rounds
Show as table · 2 funding rounds
2 funding rounds
Rounds2
Axis2018 to 2026
Series A · 12 Nov 2021US$ 27.0M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under AUM Biosciences?

One Singapore entity on ACRA. AUM BIOSCIENCES PTE. LTD. (UEN 201810204D), high confidence.

How many people work at AUM Biosciences?

The record holds 19 counted staff profiles at January 2026, inside the self-reported 11–50 band.

Where does AUM Biosciences have offices?

Three addresses on record across 3 countries. Primary: 10 Collyer Quay, Level 40, Singapore 049315.

Has AUM Biosciences raised funding?

Two rounds. Latest 12 November 2021: Series A, US$27,000,000, investors SPRIM and Everlife.

What does AUM Biosciences list as its specialties?

Eight tags on the brand's own list, among them biotech, oncology and cancer.

Which companies are listed alongside AUM Biosciences?

Four peer profiles on record: Biotech Connection Singapore and ACM Biolabs.

What is AUM Biosciences's website?